Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SPNE

SeaSpine (SPNE) Stock Price, News & Analysis

SeaSpine logo

About SeaSpine Stock (NASDAQ:SPNE)

Advanced Chart

Key Stats

Today's Range
$8.43
$9.67
50-Day Range
$7.03
$9.54
52-Week Range
$5.48
$14.23
Volume
1.16 million shs
Average Volume
822,700 shs
Market Capitalization
$354.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

SeaSpine Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
11th Percentile Overall Score

SPNE MarketRank™: 

SeaSpine scored higher than 11% of companies evaluated by MarketBeat, and ranked 882nd out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for SeaSpine.

  • Earnings Growth

    Earnings for SeaSpine are expected to grow in the coming year, from ($1.62) to ($1.30) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SeaSpine is -5.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SeaSpine is -5.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    SeaSpine has a P/B Ratio of 1.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for SPNE.
  • Dividend Yield

    SeaSpine does not currently pay a dividend.

  • Dividend Growth

    SeaSpine does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for SPNE.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for SeaSpine this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, SeaSpine insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.32% of the stock of SeaSpine is held by insiders.

  • Percentage Held by Institutions

    70.81% of the stock of SeaSpine is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about SeaSpine's insider trading history.
Receive SPNE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SeaSpine and its competitors with MarketBeat's FREE daily newsletter.

SPNE Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Spine Biologics Market Size to Achieve USD 6.95 Bn by 2033
Q2 2024 Orthofix Medical Inc Earnings Call
See More Headlines

SPNE Stock Analysis - Frequently Asked Questions

SeaSpine Holdings Co. (NASDAQ:SPNE) released its quarterly earnings data on Thursday, October, 28th. The medical equipment provider reported ($0.48) earnings per share for the quarter, missing analysts' consensus estimates of ($0.31) by $0.17. The business's quarterly revenue was up 7.5% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that SeaSpine investors own include AbbVie (ABBV), Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Amarin (AMRN), Alphatec (ATEC), Meta Platforms (META) and uniQure (QURE).

Company Calendar

Last Earnings
10/28/2021
Today
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SPNE
CIK
1637761
Fax
N/A
Employees
523
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$54.35 million
Net Margins
-28.22%
Pretax Margin
-28.83%
Return on Equity
-22.16%
Return on Assets
-17.09%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
3.18
Quick Ratio
1.65

Sales & Book Value

Annual Sales
$191.45 million
Price / Sales
1.85
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.57 per share
Price / Book
1.11

Miscellaneous

Outstanding Shares
37,203,000
Free Float
33,736,000
Market Cap
$354.92 million
Optionable
Optionable
Beta
1.31

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:SPNE) was last updated on 8/11/2025 by MarketBeat.com Staff
From Our Partners